Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuropathology and Applied Neurobiology

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/nan.12253PMID 26095752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Huntington's Disease (HD): Neurodegeneration of Brodmann's Primary Visual Area 17 (BA17)

  2015cited by this paper
• Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies

  2014cited by this paper
• Huntington's Disease (HD): Degeneration of Select Nuclei, Widespread Occurrence of Neuronal Nuclear and Axonal Inclusions in the Brainstem

  2014cited by this paper
• Barcoding heat shock proteins to human diseases: looking beyond the heat shock response

  2014cited by this paper
• Neuropathological Diagnostic Considerations in Hyperkinetic Movement Disorders

  2013cited by this paper
• DNAJ proteins and protein aggregation diseases.

  2013cited by this paper
• Neuropathological Diagnostic Considerations in Hyperkinetic Movement Disorders

  2013cited by this paper
• PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone.

  2013cited by this paper
• Degeneration of the Cerebellum in Huntington's Disease (HD): Possible Relevance for the Clinical Picture and Potential Gateway to Pathological Mechanisms of the Disease Process

  2013cited by this paper
• Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.

  2013cited by this paper
• Protein aggregates in Huntington's disease.

  2012cited by this paper
• Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3)

  2012cited by this paper
• Brain pathology of spinocerebellar ataxias

  2012cited by this paper
• Pathoanatomy of Cerebellar Degeneration in Spinocerebellar Ataxia Type 2 (SCA2) and Type 3 (SCA3)

  2011cited by this paper
• The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.

  2011cited by this paper
• Low levels of mutant ubiquitin are degraded by the proteasome in vivo

  2010cited by this paper
• A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.

  2010cited by this paper
• Levels of DNAJB family members (HSP40) correlate with disease onset in patients with spinocerebellar ataxia type 3

  2010cited by this paper
• Axonal inclusions in spinocerebellar ataxia type 3

  2010cited by this paper
• The HSP70 chaperone machinery: J proteins as drivers of functional specificity

  2010cited by this paper
• The human premotor oculomotor brainstem system – can it help to understand oculomotor symptoms in Huntington's disease?

  2009cited by this paper
• Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3

  2009cited by this paper
• Huntington's disease: from pathology and genetics to potential therapies.

  2008cited by this paper
• Polyglutamine neurodegeneration: protein misfolding revisited.

  2008cited by this paper
• Use of p62/SQSTM1 antibodies for neuropathological diagnosis

  2008cited by this paper
• The Deubiquitinating Enzyme Ataxin-3, a Polyglutamine Disease Protein, Edits Lys63 Linkages in Mixed Linkage Ubiquitin Chains*

  2008cited by this paper
• Huntington's disease

  2007cited by this paper
• Trinucleotide repeat disorders.

  2007cited by this paper
• Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.

  2007cited by this paper
• p62/SQSTM1: A Missing Link between Protein Aggregates and the Autophagy Machinery

  2006cited by this paper
• Non-invasive ventilation in amyotrophic lateral sclerosis.

  2006cited by this paper
• Signaling, Polyubiquitination, Trafficking, and Inclusions: Sequestosome 1/p62's Role in Neurodegenerative Disease

  2006cited by this paper
• Degeneration of ingestion‐related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7

  2006cited by this paper
• p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

  2005cited by this paper
• Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways.

  2005cited by this paper
• HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells.

  2005cited by this paper
• Development by self-digestion: molecular mechanisms and biological functions of autophagy.

  2004cited by this paper
• Huntington’s disease genetics

  2004cited by this paper
• Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

  2004cited by this paper
• Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.

  2004cited by this paper
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

  2004cited by this paper
• Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado–Joseph disease

  2003cited by this paper
• Impairment of proteasome structure and function in aging.

  2002cited by this paper
• Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions

  2002cited by this paper
• CREB-binding protein sequestration by expanded polyglutamine.

  2000cited by this paper
• Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold.

  1999cited by this paper
• Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology

  1999cited by this paper
• The ubiquitin–proteasome pathway: on protein death and cell life

  1998cited by this paper
• Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients.

  1998cited by this paper
• Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997cited by this paper
• Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

  1995cited by this paper
• CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

  1994cited by this paper
• Interactions of Dopamine with Glutamate‐ and GABA‐mediated Synaptic Transmission in the Rat Entorhinal Cortex In Vitro

  1993cited by this paper
• Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number.

  1993cited by this paper
• Allocortical involvement in Huntington's disease

  1992cited by this paper
• Dinucleotide repeat polymorphism for the hexabrachion gene (HXB) on chromosome 9q32-34.

  1992cited by this paper
• Adenosine A1 receptor-mediated inhibition of adenylate cyclase in rabbit retina

  1987cited by this paper
• Neuropathological Classification of Huntington's Disease

  1985cited by this paper
• Huntington's disease

  1984cited by this paper
• Die Amyloidnatur der kongophilen, drusigen Entartung der Hirnarterien (Scholz) im Senium

  1965cited by this paper
• Restoration of diaphragmatic function following vagophrenic anastomosis in the rat.

  1959cited by this paper
• The Fine Structure of the Adipose Cell of the Leech Glossiphonia complanata

  1958cited by this paper
• Autonomic Nerve and Brain Wave. (Report 1) Type of the Autonomic Nervous Tension and the Brain Wave

  1947cited by this paper

• Polyglutamine disorders: Pathogenesis and potential drug interventions.

  2024cites this paper
• Synthetic Activators of Autophagy

  2024cites this paper
• Metabolic deregulation associated with aging modulates protein aggregation in the yeast model of Huntington’s disease

  2023cites this paper
• Ribosomal protein SA is a common component of neuronal intranuclear inclusions in polyglutamine diseases and Marinesco bodies

  2023cites this paper
• The structural plasticity of polyglutamine repeats.

  2023cites this paper
• Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy

  2022cites this paper
• Altered glucose metabolism and its association with carbonic anhydrase 8 in Machado-Joseph Disease

  2022cites this paper
• HSF1 and Its Role in Huntington's Disease Pathology.

  2022cites this paper
• Nuclear poly-glutamine aggregates rupture the nuclear envelope and hinder its repair

  2022cites this paper
• Lignin-carbohydrate complexes suppress SCA3 neurodegeneration via upregulating proteasomal activities.

  2022cites this paper
• Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools

  2022cites this paper
• Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies

  2021cites this paper
• Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview

  2021cites this paper
• Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?

  2021cites this paper
• Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons

  2021cites this paper
• Clinical and pathologic phenotype of a large family with heterozygous STUB1 mutation

  2020cites this paper
• DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis.

  2020cites this paper
• Proteasome Subunits Involved in Neurodegenerative Diseases.

  2020cites this paper
• Quality Control in Huntington’s Disease: a Therapeutic Target

  2019cites this paper
• Targeting the proteostasis network in Huntington’s disease

  2019cites this paper
• The Role of MicroRNAs in Spinocerebellar Ataxia Type 3.

  2019cites this paper
• Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets

  2019cites this paper
• A Comprehensive Review of Autophagy and Its Various Roles in Infectious, Non-Infectious, and Lifestyle Diseases: Current Knowledge and Prospects for Disease Prevention, Novel Drug Design, and Therapy

  2019cites this paper
• The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells

  2019cites this paper
• Regulation of protein homeostasis in acute and chronic stress

  2019cites this paper
• Far-infrared Radiation Improves Motor Dysfunction and Neuropathology in Spinocerebellar Ataxia Type 3 Mice

  2018cites this paper
• Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons

  2018cites this paper
• Upregulation of miR-370 and miR-543 is associated with reduced expression of heat shock protein 40 in spinocerebellar ataxia type 3

  2018cites this paper
• Cerebellar lncRNA Expression Profile Analysis of SCA3/MJD Mice

  2018cites this paper
• Machado–Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy

  2018cites this paper
• The identification of cell non-autonomous roles of astrocytes in neurodegeneration

  2018cites this paper
• Trinucleotide repeat disorders.

  2017cites this paper
• On protein quality control, myofibrillar myopathies, and neurodegeneration

  2017cites this paper
• Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3

  2017cites this paper
• The Ubiquitin Proteasome System and Cerebellar Developmental Disease

  2017cites this paper
• On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3

  2017cites this paper
• Polyglutamine ataxias: From Clinical and Molecular Features to Current Therapeutic Strategies

  2017cites this paper
• Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell‐type‐specific

  2016cites this paper
• Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use

  2016influential citation
• Protein aggregation and ER stress.

  2016cites this paper
• Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3.

  2016influential citation
• Far-infrared radiation protects viability in a cell model of Spinocerebellar Ataxia by preventing polyQ protein accumulation and improving mitochondrial function

  2016cites this paper
• Heat shock proteins as potential targets for protective strategies in neurodegeneration.

  2016cites this paper